Summary:
Global Fund Lp Lind II, a major shareholder of ReWalk Robotics Ltd. (NASDAQ: RWLK), has recently purchased additional shares of the company’s stock. On September 5th, Global Fund Lp Lind II acquired 19,779 shares at an average cost of $0.70 per share. This transaction follows a series of previous purchases made by Global Fund Lp Lind II over the past few months. The insider now holds a total of 4,858,649 shares in ReWalk Robotics. These transactions were disclosed in documents filed with the SEC, as required for shareholders who own 10% or more of a company’s shares.
ReWalk Robotics is a medical device company that specializes in designing, developing, and commercializing robotic exoskeletons for individuals with mobility impairments. Their products, such as the ReWalk Personal and ReWalk Rehabilitation, provide spinal cord injury patients with the ability to walk independently. The company also offers the ReStore, a soft exo-suit for individuals with lower limb disabilities, and other biofeedback devices for movement therapy.
Despite these recent stock purchases, ReWalk Robotics’ share prices have been trading down 1.4%. On September 8th, the stock opened at $0.68, with a 50-day moving average of $0.71 and a 200-day moving average of $0.67. The company’s fifty-two week low and high are $0.56 and $1.01, respectively.
ReWalk Robotics released its quarterly earnings data on August 11th, reporting better-than-expected earnings per share of ($0.05) compared to the consensus estimate of ($0.07). Sell-side analysts project that the company will post a negative EPS of -0.35 for the current fiscal year.
Several equities research analysts have issued reports on ReWalk Robotics, including HC Wainwright who restated a “buy” rating with a price target of $3.00. However, StockNews.com initiated coverage with a “sell” rating for the company.
Various hedge funds and institutional investors have modified their holdings in ReWalk Robotics. Renaissance Technologies LLC, Millennium Management LLC, and Virtu Financial LLC are a few examples of companies that have increased their stakes in the company.
Overall, Global Fund Lp Lind II’s continuous stock purchases suggest confidence in the future prospects of ReWalk Robotics. As the company continues to develop and market its innovative medical devices, there is potential for growth in the mobility assistive technology market.
Sources:
– SEC Filings
– Nasdaq